Caption Management’s Mersana Therapeutics MRSN Stock Holding History

Caption Management’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-408	Closed	-$19.3K	–	1913
2024 Q3	$19.3K	Hold	408	–	–	﹤0.01%	1206
2024 Q2	$20.5K	Buy	+408	New	+$29.5K	﹤0.01%	1084
2023 Q3	–	Sell	-7,240	Closed	-$595K	–	1631
2023 Q2	$595K	Sell	7,240 -4,596	-39%	-$672K	0.11%	784
2023 Q1	$1.22M	Buy	+11,836	New	+$1.66M	0.26%	585
2022 Q4	–	Hold	0	–	–	–	1741
2021 Q3	–	Sell	-2,188	Closed	-$742K	–	1865
2021 Q2	$742K	Sell	2,188 -7,658	-78%	-$2.9M	0.07%	962
2021 Q1	$3.98M	Buy	+9,846	New	+$4.78M	0.51%	307
2020 Q4	–	Hold	0	–	–	–	1308

Other funds holding MRSN

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return